Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2024 Earnings Call Transcript February 26, 2025
Theravance Biopharma, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $0.26.
Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma Fourth Quarter and Full Year 2024 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal...
